its about your body sending signals that youre satisfied
Guidelines and recommendations from various medical bodies, including the American Diabetes Association (ADA), European Society of Cardiology, and Diabetes Canada, have advocated for adding an SGLT2i following the use of a GLP-1RA, or vice versa, for T2DM patients with a high risk of developing ASCVD and those with CKD [68,69,70]
V., Goehring I., et al
NAD+ supports mitochondrial energy production through the NAD+/NADH ratio
A Danish-Norwegian cohort study that looked at a larger population of type 2 diabetes patients only, and compared semaglutide to a more specific kind of diabetes medication (sodium-glucose co-transporter 2 inhibitors, or SGLT-2is), also identified a greater relative risk of NAION among semaglutide users although the absolute risk was a lot lower than what we saw in the JAMA study